Global Biosurgery Market Segments 2024, Forecast To 2033
5 Mar, 2024
The biosurgery market has shown strong growth, increasing from $14.01 billion in 2023 to $15.18 billion in 2024, achieving a CAGR of 8.4%. Contributing factors include increasing surgical procedures, rise in chronic diseases, growing geriatric population, shift towards biodegradable products, and regulatory changes and approvals. Expecting strong growth, the market is forecasted to reach $20.87 billion in 2028, maintaining a CAGR of 8.3%. Drivers include advancements in tissue engineering, rise in minimally invasive procedures, focus on regenerative medicine, shift towards biologics, and aging population needs. Major trends include growth in minimally invasive procedures, rise in cosmetic and plastic surgeries, focus on stem cell therapies, advancements in wound care, and development of biodegradable products.
Global Biosurgery Market Key Driver
The biosurgery market is poised for growth due to the increasing prevalence of chronic diseases. Chronic illnesses, affecting 78.6% of Australians according to the Australian Bureau of Statistics, necessitate advanced medical interventions like biosurgery. This field aids in the treatment of chronic wounds, minimizing infection risks and expediting the healing process, addressing the rising need for effective healthcare solutions.
Get A Free Sample Of The Global Biosurgery Market ReportGlobal Biosurgery Market Segments
The biosurgery market covered in this report is segmented –
1) By Product: Bone-Graft Substitutes, Soft-Tissue Attachments, Hemostatic Agents, Surgical Sealants and Adhesives, Adhesion Barriers, Staple Line Reinforcement
2) By Source: Natural or Biologics Products, Synthetic Products
3) By Application: Orthopedic Surgery, General Surgery, Neurological Surgery, Cardiovascular Surgery, Gynecological Surgery, Other Applications
4) By End-User: Hospitals, Clinics, Other End-Users
By Geography: The regions covered in the anti inflammatory therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe,North America, South America, Middle East, and Africa. Among these regions.
North America was the largest region in the biosurgery market in 2023. Asia-Pacific is expected to be the fastest-growing region in the biosurgery market report during the forecast period. The regions covered in the biosurgery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Major Biosurgery Industry Players
Baxter International Inc.; B. Braun SE; Becton, Dickinson and Company; Hemostasis LLC; Integra LifeSciences Corporation; Johnson & Johnson Services Inc.; CryoLife Inc.; CSL Limited; Pfizer Inc.; Zimmer Biomet Holdings Inc.; Kuros Biosciences AG; Orthofix Medical Inc.; Smiths & Nephew plc; Medtronic plc; Stryker Corp.; Betatech Medical; Tissue Regenix Group plc; Aroa Biosurgery Ltd.; Anika Therapeutics Inc.; Arthrex Inc.; B Braun Surgical SA; Biom'Up SA; Boston Scientific Corporation; Coloplast Corp.; Cook Medical Inc.; Endo International plc; Genzyme Corporation; Takeda Pharmaceutical Company Limited; Cerus Corporation
Get The Full Global Biosurgery Market Report
AIOps Biosurgery Market Overview
Biosurgery refers to the practice of using live maggots to remove dead tissue from wounds, reduce the risk of infection, and hasten wound healing. It primarily consists of semi-synthetic, synthetic, or natural materials that aid in the healing of surgical incisions and the restoration of tissue.
Biosurgery Global Market Report 2023 provides data on the global biosurgery market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The biosurgery market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.